BDBM590808 6-(5-(difluoromethoxy)pyridin-2-yl)-N-(1-(4- fluorophenyl)ethyl)-1-(2-morpholinoethyl)-2-oxo- 1,2-dihydro-1,8-naphthyridine-3-carboxamide::US11564928, Compound 55

SMILES CC(NC(=O)c1cc2cc(cnc2n(CCN2CCOCC2)c1=O)-c1ccc(OC(F)F)cn1)c1ccc(F)cc1

InChI Key InChIKey=MKBDKTCIMDHMTA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590808   

TargetCannabinoid receptor 1(Homo sapiens (Human))
Teon Therapeutics

US Patent
LigandPNGBDBM590808(6-(5-(difluoromethoxy)pyridin-2-yl)-N-(1-(4- fluo...)
Affinity DataIC50:  2.94E+3nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Teon Therapeutics

US Patent
LigandPNGBDBM590808(6-(5-(difluoromethoxy)pyridin-2-yl)-N-(1-(4- fluo...)
Affinity DataIC50:  0.600nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent